Clinical Trial Update: PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial assessing PIN in combination with sintilimab for previously treated colorectal cancer with liver metastases; the study status is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PIN (PIN)
• Sintilimab (sintilimab)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Colorectal Cancer, Adult | Phase 1 | Status: NOT_YET_RECRUITING